<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: center; text-indent: -1.5in"><B>UNITED STATES</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: center; text-indent: -1.5in"><B>SECURITIES
AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">WASHINGTON, D.C. 20549</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FORM 8-K</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">PURSUANT TO SECTION 13 OR 15(D) OF</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">THE SECURITIES EXCHANGE ACT OF 1934</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">Date of Report (Date of earliest event reported):
December 24, 2012</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>AMASYS Corporation</U></B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact Name of Registrant as Specified in Charter)</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><U>&#9;Delaware&#9;</U>&#9;<U>&#9;0-21555&#9;</U>&#9;<U>&#9;54-1812385&#9;</U></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">(State or Other Jurisdiction&#9;(Commission File No.)&#9;(I.R.S.
Employer</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">of Incorporation)&#9;Identification No.)</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><U>6462 Little River Turnpike, Suite E, Alexandria, Virginia&#9;</U>&#9;
<U>22312</U></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">(Address of Principal Executive Offices) &#9;(Zip Code)</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Registrant&rsquo;s telephone number, including area code:&#9;<U>(703)
797-8111</U></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>Not Applicable</U></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Former name or former address, if changed since
last report)</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">[ ] Written communications pursuant to Rule
425 under the Securities Act (17 CFR 230.425)</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">[ ] Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">[ ] Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">CFR 240.14d-2(b))</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">[ ] Pre-commencement communications pursuant
to Rule 13e-4(c) under the Exchange Act (17</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: -1.5in">CFR 240.13e-4(c))</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo --><!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><B><U>&nbsp;</U></B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><B><U>Safe Harbor Statement under the Private Securities Litigation
Reform Act of 1995</U></B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Information included in
this Form 8-K may contain forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of
the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;). This information may involve known and unknown
risks, uncertainties and other factors which may cause the actual results, performance or achievements of Amasys Corporation. (&ldquo;Amasys&rdquo;)
and StemGen Inc. (&ldquo;StemGen&rdquo;) (collectively, Amasys and StemGen are referred to herein as the &ldquo;Companies&rdquo;)
to be materially different from future results, performance or achievements expressed or implied by any forward-looking statements.
Forward-looking statements, which involve assumptions and describe future plans, strategies and expectations of the Companies,
are generally identifiable by use of the words &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo; &ldquo;expect,&rdquo;
&ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo; &ldquo;believe,&rdquo; &ldquo;intend&rdquo; or &ldquo;project&rdquo; or the negative
of these words or other variations on these words or comparable terminology. Forward-looking statements are based on assumptions
that may be incorrect, and there can be no assurance that any projections or other expectations included in any forward-looking
statements will come to pass. The actual results of the Companies could differ materially from those expressed or implied by the
forward-looking statements as a result of various factors. Except as required by applicable laws, Amasys undertakes no obligation
to update publicly any forward-looking statements for any reason, even if new information becomes available or other events occur
in the future.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in"><B>Item 1.01&#9;Entry
into a Material Definitive Agreement</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On December 24, 2012, Amasys
Corporation., a Delaware corporation, received a deposit under a Letter of Intent (&ldquo;LOI&rdquo;) which it entered into on
December 11, 2012 with StemGen Inc. a Nevada corporation.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Under the LOI, if all conditions
are satisfied or waived the following will take place (a) transfer all of the intellectual property rights and operations of StemGen
into the direct ownership and control of Amasys; and (b) transfer all of the equity interests of StemGen into the direct ownership
and control of Amasys. The LOI is subject the company performing a reverse stock split of 1 for 80 and changing the name to StemGen.
StemGen will pay Amasys an amount in cash equal to $325,000 at closing of which a 10% non-refundable deposit is due upon signing
of the LOI. A definitive agreement will set forth the specific terms of the transaction. The definitive agreement shall contain
standard representations and warranties. A copy of the LOI is attached to this Current Report on Form 8-K as Exhibit 99.1 and is
incorporated herein by reference.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><B>Item 9.01.&#9;<U>Financial Statements and Exhibits</U></B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">(d) &#9;Exhibits.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><U>Exhibit No.</U>&#9;<U>Description</U></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 1.5in"><FONT STYLE="font-size: 11pt">99.1</FONT></TD><TD><FONT STYLE="font-size: 11pt">Letter of Intent dated December 11, 2012</FONT></TD></TR></TABLE>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">SIGNATURES</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned,
hereunto duly authorized.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>AMASYS CORPORATION</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">DATE: December 31, 2012&#9;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">By: &#9;<U>/s/ C.W.
Gilluly, Ed.D.&#9;</U></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22pt">&#9;&#9;C.W. Gilluly, Ed.D.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22pt">&#9;&#9;President and Chief Executive Officer</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "amas121231.htm", "description": "FORM 8-K DECEMBER 24, 2012", "secsgml_size_bytes": 13734}]
{"company-data": {"conformed-name": "AMASYS CORP", "cik": "0001023198", "assigned-sic": "6799", "irs-number": "541812385", "state-of-incorporation": "DE", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-21555", "film-number": "121292758"}, "business-address": {"street1": "625 N. WASHINGTON ST.", "street2": "SUITE 301", "city": "ALEXANDRIA", "state": "VA", "zip": "22314", "phone": "703-797-8111"}, "mail-address": {"street1": "625 N. WASHINGTON ST.", "street2": "SUITE 301", "city": "ALEXANDRIA", "state": "VA", "zip": "22314"}}
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
December 24, 2012
AMASYS Corporation
(Exact Name of Registrant as Specified in Charter)
Delaware
0-21555
54-1812385
(State or Other Jurisdiction	(Commission File No.)	(I.R.S.
Employer
of Incorporation)	Identification No.)
6462 Little River Turnpike, Suite E, Alexandria, Virginia
22312
(Address of Principal Executive Offices) 	(Zip Code)
Registrant's telephone number, including area code:
(703)
797-8111
Not Applicable
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule
425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant
to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
-
Safe Harbor Statement under the Private Securities Litigation
Reform Act of 1995
Information included in
this Form 8-K may contain forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of
the Securities Exchange Act of 1934, as amended (the "Exchange Act"). This information may involve known and unknown
risks, uncertainties and other factors which may cause the actual results, performance or achievements of Amasys Corporation. ("Amasys")
and StemGen Inc. ("StemGen") (collectively, Amasys and StemGen are referred to herein as the "Companies")
to be materially different from future results, performance or achievements expressed or implied by any forward-looking statements.
Forward-looking statements, which involve assumptions and describe future plans, strategies and expectations of the Companies,
are generally identifiable by use of the words "may," "will," "should," "expect,"
"anticipate," "estimate," "believe," "intend" or "project" or the negative
of these words or other variations on these words or comparable terminology. Forward-looking statements are based on assumptions
that may be incorrect, and there can be no assurance that any projections or other expectations included in any forward-looking
statements will come to pass. The actual results of the Companies could differ materially from those expressed or implied by the
forward-looking statements as a result of various factors. Except as required by applicable laws, Amasys undertakes no obligation
to update publicly any forward-looking statements for any reason, even if new information becomes available or other events occur
in the future.
Item 1.01	Entry
into a Material Definitive Agreement
On December 24, 2012, Amasys
Corporation., a Delaware corporation, received a deposit under a Letter of Intent ("LOI") which it entered into on
December 11, 2012 with StemGen Inc. a Nevada corporation.
Under the LOI, if all conditions
are satisfied or waived the following will take place (a) transfer all of the intellectual property rights and operations of StemGen
into the direct ownership and control of Amasys; and (b) transfer all of the equity interests of StemGen into the direct ownership
and control of Amasys. The LOI is subject the company performing a reverse stock split of 1 for 80 and changing the name to StemGen.
StemGen will pay Amasys an amount in cash equal to $325,000 at closing of which a 10% non-refundable deposit is due upon signing
of the LOI. A definitive agreement will set forth the specific terms of the transaction. The definitive agreement shall contain
standard representations and warranties. A copy of the LOI is attached to this Current Report on Form 8-K as Exhibit 99.1 and is
incorporated herein by reference.
Item 9.01.
Financial Statements and Exhibits
(d) 	Exhibits.
Exhibit No.
Description
99.1
Letter of Intent dated December 11, 2012
-
2
-
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned,
hereunto duly authorized.
AMASYS CORPORATION
DATE: December 31, 2012
By:
/s/ C.W.
Gilluly, Ed.D.
C.W. Gilluly, Ed.D.
President and Chief Executive Officer